Plaintiffs’ Lawyers Accuse Bayer, J&J of Misleading Medical Journal on Xarelto
A footnote in a plaintiff’s brief in a federal lawsuit against two major pharmaceutical companies has led the New York Times to pose an unsettling question: did Bayer and Johnson & Johnson mislead the editors of a leading medical journal in an effort to protect Xarelto, an anti-clotting drug that is a sales blockbuster for…
Details